In a significant development for the rare disease community, Cellares and Papillon Therapeutics have announced a strategic collaboration aimed at…
Read More
Identification of CD99L2 Gene Variants as a Novel Driver of X-linked Spastic Ataxia Unlocks New Pathways in Neurodegenerative Research
In a significant breakthrough for the field of clinical genetics and neurology, a collaborative team of researchers in Germany has…
Read More
German Researchers Identify CD99L2 Gene as Key Driver of X-linked Spastic Ataxia
In a major advancement for the field of neurogenetics, a collaborative team of scientists in Germany has identified a previously…
Read MoreYOU MAY HAVE MISSED
